With a three-decade-plus journey in the oncology space, Hevia and Sousa spoke to the company’s developments in lung, bladder, and colorectal cancer, as announced at both ESMO and WCLC, as well as what ...

With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

The approach can be transformative. When patients feel heard and understood, they’re more likely to engage actively and ...

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one ...

A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...

In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth. But how can marketers balance personalised engagement while ensuring ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The atrial fibrillation (AFib) detection feature on Apple Watch devices has become the first digital health technology to be qualified under a programme recently introduced by the FDA designed to ...

Rates of cancer among people aged 24 and below are rising fast, but health systems are often not catering well enough to the specific needs of this age group. A new partnership has been set up ...